What's new? Log in Free sign up

Pulmatrix (PULM)

Company Profile

Company profile

Ticker

PULM

Exchange

Website

www.pulmatrix.com

CEO

Mr. Peter Ludlum CMA, MBA

Incorporated

Location

Fiscal year end

Sector

Health Technology > Biotechnology

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Entergy Arkansas • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb ...

Former names

[object Object]

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

PULM stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Submission of Matters to a Vote of Security Holders

Annual report to shareholders

Definitive proxy

8 Nov 24

Quarterly report

8 Nov 24

Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Departure of Directors or Certain Officers

Notice of effectiveness

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

Shelf registration

Latest ownership filings

View all

SABBY MANAGEMENT, LLC

INTRACOASTAL CAPITAL, LLC

Michelle Siegert

Margaret Wasilewski

Teofilo David Raad

Michael J Higgins

Christopher Cabell

Richard P. Batycky

Financial summary

Financial statements Chart PULM financial data

Quarter (USD)	Sep 24	Mar 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	10.79 mm	10.79 mm	10.79 mm	10.79 mm	10.79 mm	10.79 mm
Cash burn (monthly)	2.33 mm	1.39 mm	885.67 k	672.83 k	8.00 k	741.33 k
Cash used (since last report)	6.55 mm	3.90 mm	2.49 mm	1.89 mm	22.53 k	2.09 mm
Cash remaining	4.24 mm	6.89 mm	8.30 mm	8.90 mm	10.77 mm	8.70 mm
Runway (months of cash)	1.8	5.0	9.4	13.2	1346.2	11.7

Beta Read what these cash burn values mean

Financial data from Pulmatrix earnings reports.

Institutional ownership, Q2 2023

PULM institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	18	21	-14.3%
Opened positions	1	4	-75.0%
Closed positions	4	2	+100.0%
Increased positions	1	4	-75.0%
Reduced positions	5	3	+66.7%

13F shares	Current	Prev Q	Change
Total value	815.15 mm	1.18 bn	-31.0%
Total shares	4.67 mm	4.76 mm	-1.8%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
CVI Investments	2.46 mm	$0.00	0.0%
FiveT Investment Management	928.94 k	$1.87 mm	0.0%
Arch Venture Fund VII	458.65 k	$436.00 k	0.0%
Bigger Capital Fund L P	295.79 k	$266.00 k	0.0%
Sabby Management	184.07 k	$493.32 mm	-16.3%
Renaissance Technologies	109.01 k	$292.00 k	+3.2%
Intracoastal Capital	100.32 k	$0.00	0.0%
BLK BlackRock	54.90 k	$147.13 mm	0.0%
Geode Capital Management	24.62 k	$65.99 mm	-0.8%
Vanguard	21.39 k	$57.33 mm	-48.7%

Largest transactions	Shares	Bought/sold	Change
Sabby Management	184.07 k	-35.96 k	-16.3%
Susquehanna International	0.00	-24.91 k	EXIT
Vanguard	21.39 k	-20.29 k	-48.7%
Citadel Advisors	0.00	-15.17 k	EXIT
HRT Financial	12.11 k	+12.11 k	NEW
UBS UBS	1.10 k	-5.72 k	-83.9%
Renaissance Technologies	109.01 k	+3.39 k	+3.2%
Tower Research Capital	2.83 k	-722.00	-20.4%
Geode Capital Management	24.62 k	-206.00	-0.8%
JPM JPMorgan Chase & Co.	0.00	-100.00	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Pulmatrix And Cullgen Announce Proposed Merger; Pre-Merger Pulmatrix Stockholers To Own ~3.6% Of Combined Company; Pre-Merger Cullgen Stockholders To Own ~96.4% Of Combined Company Under Name Cullgen

Merger to create a Nasdaq-listed company focusing on targeted protein degradation technology with three degrader programs in or about to initiate Phase 1 clinical trials – two for the treatment of cancer

Pulmatrix Q3 EPS $(0.71) Up From $(1.03) YoY, Sales $366.00K Down From $1.75M YoY

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.71) per share. This is a 31.07 percent increase over losses of $(1.03) per share from the same period last year. The company reported $366.00 thousand in sales

Press releases

From Benzinga Pro

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, BERY, PULM on Behalf of Shareholders

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary

Kuehn Law Encourages BCOV, BERY, ROIC, and PULM Investors to Contact Law Firm

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders

NEW YORK, Nov. 21, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, LBRDA, ENTO, LLYVA on Behalf of Shareholders

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.